Early research (Phase 1)Study completedNCT00495417
What this trial is testing
Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Affiris AG 24